OTHER


MULTIPLE AWARDS

Individual applicants may only receive one award at a given time from the CF RIA program per cycle.

MULTIPLE AWARDS FROM THE SAME INSTITUTION

More than one application from the same institution (i.e. university, hospital) is permitted. Additionally, more than one application from the same applicant is permitted, however as noted above, applicants may only receive one award at a given time per CF RIA program cycle.

CHANGE IN AWARD RECIPIENT'S STATUS 

The transfer of an award to another institution will be at the discretion of the CF RIA program, as well as agreement between the current and new institution. Additionally, a contract with the new institution will be required.

START AND END DATES 

Research should commence upon successful execution of the contract, unless an alternative date for commencement has been approved by the Steering Committee. Failure to initiate the research within this period may result in a withdrawal of the award.

Projects should be completed within 24 months of commencement. Requests for additional time to complete research will be considered as needed. Submitted proposals will be evaluated and discussed by the Steering Committee and scored according to the Steering Committee discussion outcomes.

Based on budget requests and available funds for grants, the Steering Committee will also decide on the size of the award.

RECOMBINANT MOLECULES AND/OR ANIMAL AND HUMAN SUBJECTS 

Applicants requesting an award to carry out research with recombinant molecules and/or animal or human subjects must obtain and show proof of the required approvals from all appropriate authorities. If an applicant’s institution does not require special permission for using recombinant molecules, then this must be communicated to the CF RIA Program Manager.

The CF RIA Program Manager must receive copies of appropriate permissions before any award funds will be disbursed.

The applicant’s institution has responsibility for ensuring that the rights of any human subjects are upheld and that animals are cared for in a humane manner and follow local and international requirements as applicable, (GCP/ICH) including, but not limited to the following:

  • 21 CFR Part 50
  • 21 CFR Part 56
  • 21 CFR Part 58
  • 21 CFR Part 312
  • ICH-E6

PrivacyTerms of Use
© 2016 Vertex Pharmaceuticals Incorporated | VXR-HQ-00-00016 | 10/2016
CF RIA program funding is supported by Vertex Pharmaceuticals Incorporated

Vertex and the Vertex triangle logo are trademarks of Vertex Pharmaceuticals Incorporated